Bulletin of Mathematical Biology

, Volume 71, Issue 3, pp 720–749 | Cite as

Dynamic Modeling of Herpes Simplex Virus Type-2 (HSV-2) Transmission: Issues in Structural Uncertainty

  • Anna M. Foss
  • Peter T. Vickerman
  • Zaid Chalabi
  • Philippe Mayaud
  • Michel Alary
  • Charlotte H. Watts
Original Article


The sexually transmitted infection (STI) Herpes simplex virus type-2 (HSV-2) is of public health concern because it is a very common frequently unrecognized lifelong infection, which may facilitate HIV transmission. Within HIV/STI modeling, structural uncertainty has received less attention than parametric uncertainty. By merging the compartments of a “complex” model, a “simple” HSV-2 model is developed. Sexual interactions between female sex workers (FSWs) and clients are modeled using data from India. Latin Hypercube Sampling selects from parameter distributions and both models are run for each of the 10,000 parameter sets generated. Outputs are compared (except for 2,450 unrealistic simulations). The simple model is a good approximation to the complex model once the HSV-2 epidemic has reached 60% of the equilibrium prevalence (95% of the 7,550 runs produced <10% relative error). The simple model is a reduced version of the complex model that retains details implicitly. For late-stage epidemics, the simple model gives similar prevalence trends to the complex model. As HSV-2 epidemics in many populations are advanced, the simple model is accurate in most instances, although the complex model may be preferable for early epidemics. The analysis highlights the issue of structural uncertainty and the value of reducing complexity.


Mathematical modeling Dynamic model Model structural uncertainty Model reduction Herpes simplex virus type-2 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson, R.M., Garnett, G.P., 2000. Mathematical models of the transmission and control of sexually transmitted diseases. Sex Transm. Dis. 27(10), 636–43. CrossRefGoogle Scholar
  2. Antoulas, A.C., Sorensen, D., August 2001. Approximation of large-scale dynamical systems: an overview. http://www-ece.rice.edu/~aca/mtns00.pdf. Site accessed: 26 August 2006.
  3. Auvert, B., Puren, A., Taljaard, D., Sobngwi-Tambekou, J., Lagarde, E., Sitta, R., 2005. Can male circumcision prevent acquisition of HSV-2 infection? In: 3rd IAS Conference on HIV Pathogenesis and Treatment, 24–7 July, Rio de Janeiro, Brazil. Google Scholar
  4. Baggaley, R.F., Ferguson, N.M., Garnett, G.P., 2005. The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg. Themes Epidemiol. 2 (9) Google Scholar
  5. Benedetti, J., Corey, L., Ashley, R., 1994. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann. Int. Med. 121(11), 847–54. Google Scholar
  6. Benedetti, J.K., Zeh, J., Corey, L., 1999. Clinical reactivation of genital Herpes simplex virus infection decreases in frequency over time. Ann. Int. Med. 131(1), 14–0. Google Scholar
  7. Bentley, M.E., Morrow, K.M., Fullem, A., Chesney, M.A., Horton, S.D., Rosenberg, Z. , 2000. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam. Plann. Perspect. 32(4), 184–88. CrossRefGoogle Scholar
  8. Blower, S., 2004. Modelling the genital herpes epidemic. Herpes 11(Suppl 3), 138A–46A. Google Scholar
  9. Blower, S.M., Dowlatabadi, H., 1994. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int. Stat. Rev. 62, 229–43. MATHCrossRefGoogle Scholar
  10. Blower, S., Ma, L., 2004. Calculating the contribution of Herpes simplex virus type-2 epidemics to increasing HIV incidence: treatment implications. Clin. Infect. Dis. 39(Suppl 5), S240–S247. CrossRefGoogle Scholar
  11. Blower, S.M., Hartel, D., Dowlatabadi, H., Anderson, R.M., May, R.M., 1991. Drugs, sex and HIV: a mathematical model for New York City. Philos. Trans. R. Soc. Lond. B Biol. Sci. 331(1260), 171–87. CrossRefGoogle Scholar
  12. Blower, S.M., Porco, T.C., Darby, G., 1998. Predicting and preventing the emergence of antiviral drug resistance in HSV-2. Nat. Med. 4(6), 673–78. CrossRefGoogle Scholar
  13. Blower, S., Wald, A., Gershengorn, H., Wang, F., Corey, L., 2004. Targeting virological core groups: a new paradigm for controlling Herpes simplex virus type-2 epidemics. J. Infect. Dis. 190(9), 1610–617. CrossRefGoogle Scholar
  14. Boily, M.C., Masse, B., 1997. Mathematical models of disease transmission: a precious tool for the study of sexually transmitted diseases. Can. J. Public Health 88(4), 255–65. Google Scholar
  15. Boily, M.C., Baggaley, R.F., Wang, L., Masse, B.R., White, R.G., Hayes, R. et al., 2007a. The risk of HIV-1 infection per sexual contact in absence of antiretroviral therapy: a systematic review and meta-analysis of observational studies. In: 17th International Society for Sexually Transmitted Diseases Research, 29 July–1 August, Seattle, Washington, USA [Abstract O-058]. http://www.isstdr.org/index.php?id=97.
  16. Boily, M.C., Lowndes, C.M., Vickerman, P., Kumaranayake, L., Blanchard, J., Moses, S., , 2007b. Evaluating large-scale HIV prevention interventions: study design for an integrated mathematical modelling approach. Sex Transm. Infect. 83(7), 582–89. CrossRefGoogle Scholar
  17. Brown, Z.A., Selke, S., Zeh, J., Kopelman, J., Maslow, A., Ashley, R.L. , 1997. The acquisition of Herpes simplex virus during pregnancy. N. Engl. J. Med. 337(8), 509–16. CrossRefGoogle Scholar
  18. Brugha, R., Keersmaekers, K., Renton, A., Meheus, A., 1997. Genital herpes infection: a review. Int. J. Epidemiol. 26(4), 698–09. CrossRefGoogle Scholar
  19. Bryson, Y., Dillon, M., Bernstein, D.I., Radolf, J., Zakowski, P., Garratty, E., 1993. Risk of acquisition of genital Herpes simplex virus type-2 in sex partners of persons with genital herpes: a prospective couple study. J. Infect. Dis. 167(4), 942–46. Google Scholar
  20. Cancre, N., Tall, A., Rogier, C., Faye, J., Sarr, O., Trape, J.-F. , 2000. Bayesian analysis of an epidemiologic model of plasmodium falciparum malaria infection in Ndiop, Senegal. Am. J. Epidemiol. 152(8), 760–70. CrossRefGoogle Scholar
  21. Celum, C.L., 2004. The interaction between Herpes simplex virus and human immunodeficiency virus. Herpes 11(Suppl 1), 36A–5A. Google Scholar
  22. Cheong, W.K., Thirumoorthy, T., Doraisingham, S., Ling, A.E., 1990. Clinical and laboratory study of first episode genital herpes in Singapore. Int. J. STD & AIDS 1(3), 195–98. Google Scholar
  23. Corey, L., Handsfield, H.H., 2000. Genital herpes and public health: addressing a global problem. J. Am. Med. Assoc. 283(6), 791–94. CrossRefGoogle Scholar
  24. Corey, L., Wald, A., 1999. Sexually Transmitted Diseases, McGraw-Hill, New York. Chap. 21: Genital herpes, pp. 285–12. Google Scholar
  25. Corey, L., Adams, H.G., Brown, Z.A., Holmes, K.K., 1983a. Genital Herpes simplex virus infections: clinical manifestations, course, and complications. Ann. Intern. Med. 98(6), 958–72. Google Scholar
  26. Corey, L., Fife, K.H., Benedetti, J.K., Winter, C.A., Fahnlander, A., Connor, J.D. , 1983b. Intravenous acyclovir for the treatment of primary genital herpes. Ann. Intern. Med. 98(6), 914–21. Google Scholar
  27. Corey, L., Langenberg, A.G., Ashley, R., Sekulovich, R.E., Izu, A.E., Douglas, J.M. Jr. , 1999. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. J. Am. Med. Assoc. 282(4), 331–40. CrossRefGoogle Scholar
  28. Corey, L., Wald, A., Celum, C.L., Quinn, T.C., 2004a. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr. 35(5), 435–45. CrossRefGoogle Scholar
  29. Corey, L., Wald, A., Patel, R., Sacks, S.L., Tyring, S.K., Warren, T. , 2004b. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N. Engl. J. Med. 350(1), 11–0. CrossRefGoogle Scholar
  30. Cowan, F.M., French, R.S., Mayaud, P., Gopal, R., Robinson, N.J., de Oliveira, S.A. , 2003. Seroepidemiological study of Herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm. Infect. 79(4), 286–90. CrossRefGoogle Scholar
  31. Critchfield, G.C., Willard, K.E., 1986. Probabilistic analysis of decision trees using Monte Carlo simulation. Med. Decis. Mak. 6(2), 85–2. CrossRefGoogle Scholar
  32. Delany, S., Mayaud, P., Clayton, T., Mlaba, N., Akpomiemie, G., Hira, K. et al., 2007. Impact of HSV-2 suppressive therapy on genital and plasma HIV-1 RNA in HIV-1 and HSV-2-seropositive women not taking ART: a randomized, placebo-controlled trial in Johannesburg, South Africa. In: 14th Conference on Retroviruses and Opportunistic Infections, 25–8 February; Los Angeles, USA [Abstract 154LB]. http://www.retroconference.org/2007, accessed 28 May 2007.
  33. Diamond, C., Selke, S., Ashley, R., Benedetti, J., Corey, L., 1999. Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex Transm. Dis. 26(4), 221–25. CrossRefGoogle Scholar
  34. Dietz, K., Hadeler, K.P., 1988. Epidemiological models for sexually transmitted diseases. J. Math. Biol. 26(1), 1–5. MATHMathSciNetGoogle Scholar
  35. Doubilet, P., Begg, C.B., Weinstein, M.C., Braun, P., McNeil, B.J., 1985. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med. Decis. Mak. 5(2), 157–77. CrossRefGoogle Scholar
  36. Eames, K.T.D., Keeling, M.J., 2002. Modeling dynamic and network heterogeneities in the spread of sexually transmitted diseases. Proc. Natl. Acad. Sci. 99(20), 13330–3335. CrossRefGoogle Scholar
  37. Ferguson, N.M., Garnett, G.P., 2000. More realistic models of sexually transmitted disease transmission dynamics: sexual partnership networks, pair models, and moment closure. Sex Transm. Dis. 27(10), 600–09. CrossRefGoogle Scholar
  38. Fisman, D.N., Lipsitch, M., Hook, E.W. 3rd, Goldie, S.J., 2002. Projection of the future dimensions and costs of the genital Herpes simplex type-2 epidemic in the united states. Sex Transm. Dis. 29(10), 608–22. CrossRefGoogle Scholar
  39. Foss, A.M., Vickerman, P., Watts, C., Mayaud, P., Weiss, H., Ramesh, B.M. et al., 2007. Modeling the interactions between HSV-2 and HIV: implications for the HIV epidemic in southern India. In: 17th International Society for Sexually Transmitted Diseases Research, 29 July–1 August; Seattle, Washington, USA [Abstract 329]. http://www.isstdr.org/index.php?id=97.
  40. Freeman, E.E., Bakker, R., White, R.G., Orroth, K.K., Buve, A., Hayes, R. et al., 2006a. Four cities modelling: simulated effect of HSV-2 prophylactic vaccines on population-level HIV incidence in sub-Saharan Africa. In: XVI International AIDS Conference, 13–8 August; Toronto, Canada [Abstract TUPE0414]. http://www.iasociety.org/abstract/show.asp?abstract_id=2192424.
  41. Freeman, E.E., Weiss, H.A., Glynn, J.R., Cross, P.L., Whitworth, J.A., Hayes, R.J., 2006b. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20(1), 73–3. CrossRefGoogle Scholar
  42. Gadkari, D.A., Quinn, T.C., Gangakhedkar, R.R., Mehendale, S.M., Divekar, A.D., Risbud, A.R. , 1998. HIV-1 DNA shedding in genital ulcers and its associated risk factors in Pune, India. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18(3), 277–81. Google Scholar
  43. Garnett, G.P., Anderson, R.M., 1996. Sexually transmitted diseases and sexual behavior: insights from mathematical models. J. Infect. Dis. 17(Suppl 2), S150–S161. Google Scholar
  44. Garnett, G.P., Dubin, G., Slaoui, M., Darcis, T., 2004. The potential epidemiological impact of a genital herpes vaccine for women. Sex Transm. Infect. 80(1), 24–9. CrossRefGoogle Scholar
  45. Gershengorn, H.B., Blower, S.M., 2000. Impact of antivirals and emergence of drug resistance: HSV-2 epidemic control. AIDS Patient Care STDS 14(3), 133–42. CrossRefGoogle Scholar
  46. Gershengorn, H.B., Darby, G., Blower, S.M., 2003. Predicting the emergence of drug-resistant HSV-2: new predictions. BMC Infect. Dis. 3(1), 1. CrossRefGoogle Scholar
  47. Ghani, A.C., Aral, S.O., 2005. Patterns of sex worker-client contacts and their implications for the persistence of sexually transmitted infections. J. Infect. Dis. 1(Suppl 1), S34–S41. CrossRefGoogle Scholar
  48. Guinan, M.E., MacCalman, J., Kern, E.R., Overall, J.C. Jr., Spruance, L.S., 1981. The course of untreated recurrent genital Herpes simplex infection in 27 women. N. Engl. J. Med. 304(13), 759–63. Google Scholar
  49. Hawkes, S., Santhya, K.G., 2002. Diverse realities: sexually transmitted infections and HIV in India. Sex Transm. Infect. 78(Suppl 1), i31–i39. CrossRefGoogle Scholar
  50. Hoeting, J.A., Madigan, D., Raftery, A.E., Volinsky, C.T., 1999. Bayesian model averaging: a tutorial. Stat. Sci. 14(4), 382–17. MATHCrossRefMathSciNetGoogle Scholar
  51. Holmes, K.K., Levine, R., Weaver, M., 2004. Effectiveness of condoms in preventing sexually transmitted infections. Bull. World Health Organ. 82(6), 454–61. Google Scholar
  52. ICHAP, 2004/2005. HSV-2 prevalence of general population in Bagalkot District: sub-sample of GPS (stratified random sample). India-Canada Collaborative HIV/AIDS Project (ICHAP). Google Scholar
  53. Iman, R.L., Conover, W.J., 1982. A distribution-free approach to inducing rank correlation among input variables. Commun. Stat.: Simul. Comput. 11, 311–34. MATHCrossRefGoogle Scholar
  54. Iman, R.L., Davenport, J.M., 1982. Rank correlation plots for use with correlated input variables. Commun. Stat.: Simul. Comput. 11, 335–60. CrossRefGoogle Scholar
  55. Iman, R.L., Helton, J.C., 1988. An investigation of uncertainty and sensitivity analysis techniques for computer models. Risk Anal. 8, 71–0. CrossRefGoogle Scholar
  56. Isukapalli, S.S., Roy, A., Georgopoulos, P.G., 1998. Stochastic response surface methods (SRSMs) for uncertainty propagation: application to environmental and biological systems. Risk Anal. 18(3), 351–63. CrossRefGoogle Scholar
  57. Isukapalli, S.S., Roy, A., Georgopoulos, P.G., 2000. Efficient sensitivity/uncertainty analysis using the combined stochastic response surface method and automated differentiation: application to environmental and biological systems. Risk Anal. 20(5), 591–02. CrossRefGoogle Scholar
  58. Jacob, M., Rao, P.S., Sridharan, G., John, T.J., 1989. Epidemiology & clinical profile of genital herpes. Indian J. Med. Res. 89, 4–1. Google Scholar
  59. Joshi, S., Chandorkar, A., Krishnan, G., Walimbe, A., Gangakhedkar, R., Risbud, A. , 2001. Cervical intraepithelial changes & HIV infection in women attending sexually transmitted disease clinics in Pune, India. Indian J. Med. Res. 113, 161–69. Google Scholar
  60. KHPT, 2005. Mapping of high risk groups in (urban) Karnataka: Karnataka Health Promotion Trust (KHPT). Google Scholar
  61. KHPT, 2006. IBBA in FSW from Mysore District, Karnataka Health Promotion Trust (KHPT). Google Scholar
  62. Koelle, D.M., Benedetti, J., Langenberg, A., Corey, L., 1992. Asymptomatic reactivation of Herpes simplex virus in women after the first episode of genital herpes. Ann. Intern. Med. 116(6), 433–37. Google Scholar
  63. Korenromp, E.L., Bakker, R., De Vlas, S.J., Robinson, N.J., Hayes, R., Habbema, J.D., 2002. Can behavior change explain increases in the proportion of genital ulcers attributable to herpes in sub-Saharan Africa? A simulation modeling study. Sex Transm. Dis. 29(4), 228–38. CrossRefGoogle Scholar
  64. Kretzschmar, M., Dietz, K., 1998. The effect of pair formation and variable infectivity on the spread of an infection without recovery. Math. Biosci. 148(1), 83–13. MATHCrossRefMathSciNetGoogle Scholar
  65. Kumaranayake, L., Watts, C., Vickerman, P., Terris-Prestholt, F., 2006. Economic evaluation of HIV prevention activities: dynamic challenges for cost-effectiveness analysis. In: Roberts, J. (Ed.), The Economics of Infectious Diseases, pp. 65–3. Oxford University Press, Oxford. Google Scholar
  66. Kura, M.M., Hira, S., Kohli, M., Dalal, P.J., Ramnani, V.K., Jagtap, M.R., 1998. High occurrence of HBV among STD clinic attenders in Bombay, India. Int. J. STD AIDS 9(4), 231–33. CrossRefGoogle Scholar
  67. Lafferty, W.E., Coombs, R.W., Benedetti, J., Critchlow, C., Corey, L., 1987. Recurrences after oral and genital Herpes simplex virus infection. Influence of site of infection and viral type. N. Engl. J. Med. 316(23), 1444–449. CrossRefGoogle Scholar
  68. Langenberg, A.G., Corey, L., Ashley, R.L., Leong, W.P., Straus, S.E., 1999. A prospective study of new infections with Herpes simplex virus type-1 and type-2. Chiron HSV Vaccine Study Group. N. Engl. J. Med. 341(19), 1432–438. CrossRefGoogle Scholar
  69. Lipsitch, M., Bacon, T.H., Leary, J.J., Antia, R., Levin, B.R., 2000. Effects of antiviral usage on transmission dynamics of Herpes simplex virus type-1 and on antiviral resistance: predictions of mathematical models. Antimicrob. Agents Chemother. 44(10), 2824–835. CrossRefGoogle Scholar
  70. Manning, W.G., Fryback, D.G., Weinstein, M.C., 1996. Reflecting uncertainty in cost-effectiveness analysis. In: Gold, M., Siegel, J., Russell, L. (Eds.), Cost-effectiveness in Health and Medicine, pp. 247–75. Oxford University Press, New York. Google Scholar
  71. Mark, K.E., Wald, A., Magaret, A.S., Selke, S., Olin, L.P., Huang, M.-L. et al., 2007. Rapid onset and clearance of genital HSV reactivations in immunocompetent adults: the virus is usually “on” In: 17th International Society for Sexually Transmitted Diseases Research, 29 July – 1 August; Seattle, Washington, USA [Abstract O-030]. http://www.isstdr.org/index.php?id=97.
  72. McKay, M.D., Conover, W.J., Beckman, R.J., 1979. A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics 21, 239–46. MATHCrossRefMathSciNetGoogle Scholar
  73. Mertz, G.J., Schmidt, O., Jourden, J.L., Guinan, M.E., Remington, M.L., Fahnlander, A. , 1985. Frequency of acquisition of first-episode genital infection with Herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm. Dis. 12(1), 33–9. Google Scholar
  74. Mertz, G.J., Coombs, R.W., Ashley, R., Jourden, J., Remington, M., Winter, C. , 1988. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J. Infect. Dis. 157(6), 1169–177. Google Scholar
  75. Mertz, G.J., Benedetti, J., Ashley, R., Selke, S.A., Corey, L., 1992. Risk factors for the sexual transmission of genital herpes. Ann. Intern. Med. 116(3), 197–02. Google Scholar
  76. NACO, 2001. National baseline high risk and bridge population behavioural surveillance survey—part I (FSW and their clients) and India. http://www.nacoonline.org/publication.htm.
  77. Nagot, N., Ouedraogo, A., Foulongne, V., Konate, I., Weiss, H.A., Vergne, L. , 2007. Reduction of HIV-1 RNA levels with therapy to suppress Herpes simplex virus. N. Engl. J. Med. 356(8), 790–99. CrossRefGoogle Scholar
  78. National Informatics Centre, 2004. Official website of Bagalkot District. http://bagalkot.nic.in/. Site accessed: 19 May 2004.
  79. Newton, E.A., Kuder, J.M., 2000. A model of the transmission and control of genital herpes. Sex Transm. Dis. 27(7), 363–70. CrossRefGoogle Scholar
  80. Orroth, K.K., White, R.G., Korenromp, E.L., Bakker, R., Changalucha, J., Habbema, J.D. , 2006. Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: simulation results. Sex Transm. Dis. 33(9), 536–44. CrossRefGoogle Scholar
  81. Ramesh, B.M., Rajeswari, N.V., Sankangoudar, S., 2003. Female commercial sex workers in Karnataka: a baseline survey, 2002, Bangalore and Dharwad, India-Canada Collaborative HIV/AIDS Project (ICHAP) and Population Research Centre, March 2003. Google Scholar
  82. Rana, R.K., Pimenta, J.M., Rosenberg, D.M., Warren, T., Sekhin, S., Cook, S.F. , 2006. Sexual behaviour and condom use among individuals with a history of symptomatic genital herpes. Sex Transm. Infect. 82(1), 69–4. CrossRefGoogle Scholar
  83. Reynolds, S.J., Risbud, A.R., Shepherd, M.E., Zenilman, J.M., Brookmeyer, R.S., Paranjape, R.S. , 2003. Recent Herpes simplex virus type-2 infection and the risk of human immunodeficiency virus type-1 acquisition in India. J. Infect. Dis. 187(10), 1513–521. CrossRefGoogle Scholar
  84. Reynolds, S.J., Shepherd, M.E., Risbud, A.R., Gangakhedkar, R.R., Brookmeyer, R.S., Divekar, A.D. , 2004. Male circumcision and risk of HIV-1 and other sexually transmitted infections in India. Lancet 363(9414), 1039–040. CrossRefGoogle Scholar
  85. Rowley, J.T.F., 1992. The demographic and economic consequences of the AIDS epidemic in sub-Saharan Africa. Thesis for Doctor of Philosophy and Diploma of Imperial College in the Faculty of Science of the University of London. Ph.D. thesis, Imperial College London. Google Scholar
  86. Schacker, T., Zeh, J., Hu, H.L., Hill, E., Corey, L., 1998. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J. Infect. Dis. 178(6), 1616–622. CrossRefGoogle Scholar
  87. Schinazi, R.B., 1999. Strategies to control the genital herpes epidemic. Math. Biosci. 159(2), 113–21. MATHCrossRefMathSciNetGoogle Scholar
  88. Schwartz, E.J., Blower, S., 2005. Predicting the potential individual- and population-level effects of imperfect Herpes simplex virus type-2 vaccines. J. Infect. Dis. 191(10), 1734–746. CrossRefGoogle Scholar
  89. Schwartz, E.J., Bodine, E.N., Blower, S., 2007. Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines. Hum. Vaccin. 3(6). Google Scholar
  90. Sharma, V.K., Khandpur, S., 2004. Changing patterns of sexually transmitted infections in India. Natl. Med. J. India 17(6), 310–19. Google Scholar
  91. Spiegelhalter, D.J., Best, N.G., Carlin, B.P., van der Linde, X., 2002. A Bayesian measures of model complexity and fit. J. R. Stat. Soc. B 64(4), 583–39. MATHCrossRefGoogle Scholar
  92. Stanberry, L.R., Spruance, S.L., Cunningham, A.L., Bernstein, D.I., Mindel, A., Sacks, S. , 2002. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347(21), 1652–661. CrossRefGoogle Scholar
  93. Stein, M., 1987. Large sample properties of simulations using Latin hypercube sampling. Technometrics 29(2), 143–51. MATHCrossRefMathSciNetGoogle Scholar
  94. Sweat, M., Gregorich, S., Sangiwa, G., Furlonge, C., Balmer, D., Kamenga, C. , 2000. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 356, 113–21. CrossRefGoogle Scholar
  95. Vickerman, P., Watts, C.H., 2003. Injecting drug use and the sexual transmission of HIV: simple model insights. Int. J. Drug Policy 14, 89–3. CrossRefGoogle Scholar
  96. Wald, A., Link, K., 2002. Risk of human immunodeficiency virus infection in Herpes simplex virus type-2-seropositive persons: a meta-analysis. J. Infect. Dis. 185(1), 45–2. CrossRefGoogle Scholar
  97. Wald, A., Zeh, J., Selke, S., Ashley, R.L., Corey, L., 1995. Virologic characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J. Med. 333(12), 770–75. CrossRefGoogle Scholar
  98. Wald, A., Corey, L., Cone, R., Hobson, A., Davis, G., Zeh, J., 1997. Frequent genital Herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J. Clin. Invest. 99(5), 1092–097. CrossRefGoogle Scholar
  99. Wald, A., Zeh, J., Selke, S., Warren, T., Ryncarz, A.J., Ashley, R. , 2000. Reactivation of genital Herpes simplex virus type-2 infection in asymptomatic seropositive persons. N. Engl. J. Med. 342(12), 844–50. CrossRefGoogle Scholar
  100. Wald, A., Langenberg, A.G., Link, K., Izu, A.E., Ashley, R., Warren, T. , 2001. Effect of condoms on reducing the transmission of Herpes simplex virus type-2 from men to women. J. Am. Med. Assoc. 285(24), 3100–106. CrossRefGoogle Scholar
  101. Wald, A., Langenberg, A.G.M., Kexel, E., Izu, A., Ashley, R., Corey, L., 2002a. Condoms protect men and women against Herpes simplex virus type-2 (HSV-2) acquisition. In: National STD Prevention Conference; San Diego, CA [Abstract 274]. http://www.cdc.gov/std/Media/2002ConfAbOther2.htm.
  102. Wald, A., Zeh, J., Selke, S., Warren, T., Ashley, R., Corey, L., 2002b. Genital shedding of Herpes simplex virus among men. J. Infect. Dis. 186(Suppl 1), S34–S39. CrossRefGoogle Scholar
  103. Wald, A., Huang, M.L., Carrell, D., Selke, S., Corey, L., 2003. Polymerase chain reaction for detection of Herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J. Infect. Dis. 188(9), 1345–351. CrossRefGoogle Scholar
  104. Wald, A., Langenberg, A.G.M., Krantz, E., Douglas, J.M. Jr., Handsfield, H.H., DiCardo, R.P. , 2005. The relationship between condom use and herpes simplex virus acquisition. Ann. Intern. Med. 143(10), 707–13. Google Scholar
  105. Watts, C., Kumaranayake, L., Vickerman, P., Terris-Prestholt, F., 2002. The public health benefits of microbicides in lower-income countries. The Rockefeller Foundation 2002. http://www.rockfound.org/Documents/488/rep7_publichealth.pdf., New York.
  106. Weiss, H.A., Thomas, S.L., Munabi, S.K., Hayes, R.J., 2006. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and metaanalysis. Sex Transm. Infect. 82(2), 101–10. CrossRefGoogle Scholar
  107. White, P.J., Garnett, G.P., 1999. Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of Herpes simplex virus type-2. Sex Transm. Infect. 75(1), 49–4. CrossRefGoogle Scholar
  108. White, R.G., Orroth, K.K., Korenromp, E.L., Bakker, R., Wambura, M., Sewankambo, N.K. , 2004. Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: a modeling study. J. Acquir. Immune Defic. Syndr. 37(4), 1500–513. CrossRefGoogle Scholar
  109. Williams, J.R., Jordan, J.C., Davis, A., Garnett, G.P., 2007. Suppressive valacyclovir therapy: impact on the population spread of HSV-2 infection. Sex Transm. Dis. 34(3), 123–31. CrossRefGoogle Scholar
  110. Zuckerman, R.A., Lucchetti, A., Whittington, W.L., Sanchez, J., Coombs, R.W., Zuniga, R. , 2007. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J. Infect. Dis. 196(10), 1500–508. CrossRefGoogle Scholar

Copyright information

© Society for Mathematical Biology 2009

Authors and Affiliations

  • Anna M. Foss
    • 1
  • Peter T. Vickerman
    • 1
  • Zaid Chalabi
    • 1
  • Philippe Mayaud
    • 1
  • Michel Alary
    • 2
  • Charlotte H. Watts
    • 1
  1. 1.London School of Hygiene & Tropical MedicineLondonUK
  2. 2.Centre hospitalier affilié universitaire de QuébecQuébecCanada

Personalised recommendations